Trading in any company will carry risks though - and especially with Biotech companies at the cutting edge of research. I think the risks you listed are valid but these are known I would have thought.
IMU is cashed up and there is an elevated volume in trading. Good management decisions have put IMU in a very robust position for a Biotech that is essentially in an advanced research stage.
- Forums
- ASX - By Stock
- Imugene now valued at $3 Billion. Hello ASX200!!
Trading in any company will carry risks though - and especially...
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $400.5M |
Open | High | Low | Value | Volume |
5.5¢ | 5.6¢ | 5.4¢ | $348.9K | 6.350M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
43 | 3605410 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 200151 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 3605410 | 0.054 |
22 | 3710215 | 0.053 |
22 | 2142065 | 0.052 |
20 | 1793914 | 0.051 |
67 | 4445029 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 200151 | 13 |
0.056 | 889882 | 12 |
0.057 | 1432133 | 11 |
0.058 | 277086 | 6 |
0.059 | 637173 | 7 |
Last trade - 14.54pm 29/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |